FIELD: biotechnology.
SUBSTANCE: invention relates to a transgenic mammal containing a nucleic acid molecule integrated in its genome, coding a rearranged variable region of the light chain of human immunoglobulin and an animal light chain constant region, as well as to a method for production thereof. Also disclosed is a B-cell recovered from said transgenic mammal.
EFFECT: invention is effective for producing antibodies.
29 cl, 27 dwg, 11 tbl, 22 ex
Title | Year | Author | Number |
---|---|---|---|
ANTIBODY-PRODUCING NON-HUMAN MAMMALS | 2009 |
|
RU2559524C2 |
PRODUCING NON-HUMAN MAMMALIAN ANTIBODIES | 2009 |
|
RU2731084C2 |
TRANSGENIC ANIMALS AND METHODS OF USE | 2011 |
|
RU2580017C2 |
HUMANIZED NON-HUMAN ANIMALS WITH RESTRICTED IMMUNOGLOBULIN HEAVY CHAIN LOCI | 2013 |
|
RU2656155C2 |
SOLUBLE ANTIBODIES CONTAINING ONLY HEAVY CHAINS | 2010 |
|
RU2528737C2 |
RESTRICTED IMMUNOGLOBULIN HEAVY CHAIN MICE | 2012 |
|
RU2603090C2 |
ADAM6 MICE | 2012 |
|
RU2582261C2 |
HUMANISED LIGHT CHAIN MICE | 2012 |
|
RU2664181C2 |
NON-HUMAN ANIMALS WITH MODIFIED SEQUENCES IMMUNOGLOBULIN HEAVY CHAINS | 2014 |
|
RU2618886C2 |
ADAM6 MICE | 2012 |
|
RU2722373C2 |
Authors
Dates
2024-06-13—Published
2020-08-19—Filed